Startup Norton Signs Sales Deals Covering Europe, mid-Atlantic States | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Startup firm Norton Scientific separately announced an agreement to expand its sales presence in Europe and a deal for the sale of its products in the mid-Atlantic region.

Earlier this month, the company based in Thorold, Canada, announced a mutual distribution agreement under which AstraNet Systems, in Cambridge, UK, would sell Norton's recently launched protein aggregation monitoring, or PAM, hand-held system for the analysis of how proteins aggregate in solutions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.